Anixa Biosciences is trading 5.11% up at $3.29 versus the September 2, 2026 close of $3.13; no verified catalyst has been identified.
- The latest company update was an August 24 announcement of a September 9–11 conference presentation.
- Major U.S. futures are mixed and generally near flat, suggesting an isolated move.
- Confidence is low pending possible delayed news or additional trading data.